The Post-Pandemic Evolution of Antiviral Research
December 22, 2025
The pandemic catalyzed a transformation in antiviral R&D. From better data to open collaboration, Tetiana Matviyuk of Enamine describes how the landscape has evolved.
3 min read
False
December 22, 2025
The pandemic catalyzed a transformation in antiviral R&D. From better data to open collaboration, Tetiana Matviyuk of Enamine describes how the landscape has evolved.
3 min read
By Lisa Stehno-Bittel
December 8, 2025
Drug delivery innovation lags behind molecule discovery. Smarter polymer-based excipients can boost biologic stability, efficacy, and accessibility, transforming patient outcomes and biotech success.
3 min read
By Stephanie Vine
December 3, 2025
“For those of you who are removed from direct interaction with the patients…please remember that your work really matters. It is making a huge difference to human lives.”
3 min read
November 25, 2025
From the University of Houston to MD Anderson Cancer Center, Cole Woody’s journey shows how curiosity and collaboration can drive major discoveries...
7 min read
By Stephanie Vine
November 11, 2025
Interim results from a clinical trial addressing a fatal brain matter disorder suggest that gene therapy could be an effective approach
3 min read
October 27, 2025
By focusing on functional activity, Abalone Bio is advancing CB2-targeting antibodies with the potential to transform treatment for fibrosis, neuropathy, and beyond.
6 min read
By Stephanie Vine
October 24, 2025
We speak with a biotech CEO about the potential of psychedelic medicine – and the challenges of working with stigmatized substances.
11 min read
By Stephanie Vine
October 17, 2025
Quarraisha Abdool Karim discusses COVID-19 and why the industry must continue to invest in mRNA – and take the public along with them
11 min read
October 8, 2025
How military training and a fascination for nature have combined to build a sustainable business.
6 min read
By Rob Coker
October 7, 2025
Centuries of healing wisdom meet AI and molecular modeling, opening new possibilities for pharma pipelines.
2 min read
False
False
False